Saturday 7 November 2026
Export PGNY’s income statement to Excel — free account
Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
34.84
0.47
+1.37%
Follow PGNY
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 8 | 8 |
+8 more TTM periods Free account |
| 18.69% | 16.24% | 14.93% | 12.48% | ||
| 12.38% | 10.65% | 9.48% | 8.67% | ||
ROIC |
35.99% | 32.40% | 28.15% | 25.88% | |
Return on Tangible Assets |
33.15% | 24.97% | 22.45% | 15.43% | |
Average Days of Receivables |
67.94 | 71.70 | 74.41 | 62.39 | |
Free Cash Flow per Share |
2.36 | 2.28 | 2.28 | 2.24 | |
Free Cash Flow |
179.64 | 178.38 | 184.42 | 191.78 | |
Capital Expenditures |
(27.54) | (22.86) | (21.91) | (18.41) | |
| Other line items | |||||
Cash ROIC |
29.47% | 25.85% | 27.75% | 23.21% | |
Accounts Receivable Turnover |
5.34 | 4.95 | 4.59 | 5.66 | |
Accounts Payable Turnover |
7.42 | 6.76 | 6.47 | 8.98 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
53.72 | 56.13 | 58.70 | 46.01 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.31) | (0.34) | (0.36) | (0.39) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.48% | 16.02% | 16.65% | 17.01% | |
Share Based Compensation of Revenue |
7.18% | 8.18% | 9.21% | 10.23% | |
Operating CF/Net income |
2.28 | 2.56 | 3.05 | 3.59 | |
Depreciation/Fixed assets |
0.14 | 0.14 | 0.15 | 0.17 | |
Capex/Depreciation |
(3.90) | (3.98) | (4.12) | (3.72) | |
Revenue per Share |
17.56 | 16.77 | 15.98 | 15.05 | |
Operating CF per Share |
2.72 | 2.57 | 2.55 | 2.45 | |
Capex per Share |
(0.36) | (0.29) | (0.27) | (0.21) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 |
Columns are period end dates · fundamentals updated 6 Nov 2026